Search Results 41-50 of 783 for kolkataembark
PURPOSE: This phase II trial is studying how well giving rituximab and cyclophosphamide together with bortezomib and dexamethasone works in treating patients ...
The research of Mayo Clinic nephrologist Mira T. Keddis, M.D., focuses on improving cardiovascular evaluation and management of kidney transplant candidates and ...
The purpose of this study is to determine whether Nivolumab, in combination with brentuximab vedotin, is safe and effective in patients with certain subtypes of ...
The purpose of this study is to determine the performance of the Exact IBD-ACRN (inflammatory bowel disease-advanced colorectal neoplasia)surveillance test to ...
Her Clinical Focus Includes: Properly care for women with symptoms suggestive of heart disease; Discuss the increased cardiovascular risks related to autoimmune ...
A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...
About this study. Our aim is to study non-melanoma skin cancers (NMSC), rare and adnexal tumor outcomes in the context of the current cutaneous AJCC staging ...
About this study. This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.